DNA vaccines—how far from clinical use?

D Hobernik, M Bros - International journal of molecular sciences, 2018 - mdpi.com
Two decades ago successful transfection of antigen presenting cells (APC) in vivo was
demonstrated which resulted in the induction of primary adaptive immune responses. Due to …

Brief update on endocytosis of nanomedicines

S Patel, J Kim, M Herrera, A Mukherjee… - Advanced drug delivery …, 2019 - Elsevier
The complexity of nanoscale interactions between biomaterials and cells has limited the
realization of the ultimate vision of nanotechnology in diagnostics and therapeutics. As such …

Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles

F Sebastiani, M Yanez Arteta, M Lerche, L Porcar… - ACS …, 2021 - ACS Publications
Emerging therapeutic treatments based on the production of proteins by delivering mRNA
have become increasingly important in recent times. While lipid nanoparticles (LNPs) are …

A comparison of cellular uptake mechanisms, delivery efficacy, and intracellular fate between liposomes and extracellular vesicles

TB Gandek, L van der Koog… - Advanced healthcare …, 2023 - Wiley Online Library
A key aspect for successful drug delivery via lipid‐based nanoparticles is their
internalization in target cells. Two prominent examples of such drug delivery systems are …

Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics

F Chen, M Alphonse, Q Liu - Wiley Interdisciplinary Reviews …, 2020 - Wiley Online Library
CRISPR‐based genome editing technology has become an important potential therapeutic
tool for various diseases. A vital challenge is to reach a safe, efficient, and clinically suitable …

Intracellular delivery of nanomaterials: how to catch endosomal escape in the act

TF Martens, K Remaut, J Demeester, SC De Smedt… - Nano Today, 2014 - Elsevier
Successful cytosolic delivery of nanomaterials is becoming more and more important, given
the increase in intracellular applications of quantum dots, gold nanoparticles, liposomal drug …

Liposome–protein corona in a physiological environment: challenges and opportunities for targeted delivery of nanomedicines

G Caracciolo - Nanomedicine: Nanotechnology, Biology and Medicine, 2015 - Elsevier
Active targeting that exploits the (over) expression of surface receptors in target cells by
ligand incorporation is a central concept in nanomedicine research. Despite unprecedented …

Recent progress in nanomaterials for gene delivery applications

E Keles, Y Song, D Du, WJ Dong, Y Lin - Biomaterials science, 2016 - pubs.rsc.org
Nanotechnology-based gene delivery is the division of nanomedicine concerned with the
synthesis, characterization, and functionalization of nanomaterials to be used in targeted …

Nanoplatforms for mRNA therapeutics

C Meng, Z Chen, G Li, T Welte… - Advanced Therapeutics, 2021 - Wiley Online Library
Abstract mRNA‐based therapeutics are a unique class of drugs for treatment of human
diseases. Since in vitro transcribed mRNA molecules have relatively low stability and their …

Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate

B Sheikholeslami, NW Lam, K Dua, M Haghi - Life Sciences, 2022 - Elsevier
Liposomes, vesicles composed of a phospholipid bilayer, are considered a remarkably
advanced drug delivery system due to their unique properties, including their …